Targeting VEGF-A in myeloid cells enhances natural killer cell responses to chemotherapy and ameliorates cachexia
Chemerin is an adipokine often downregulated in tumours. Here the authors show that chemotherapy induces chemerin production by endothelial cells, leading to cachexia, and that VEGF ablation in myeloid cells prevents cachexia in a chemerin-dependent manner, and improves chemotherapeutic effects.
Guardado en:
Autores principales: | Ralph Klose, Ewelina Krzywinska, Magali Castells, Dagmar Gotthardt, Eva Maria Putz, Chahrazade Kantari-Mimoun, Naima Chikdene, Anna-Katharina Meinecke, Katrin Schrödter, Iris Helfrich, Joachim Fandrey, Veronika Sexl, Christian Stockmann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/26b59077ba8c4ef5af5427b06f0a12dc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis
por: Ewelina Krzywinska, et al.
Publicado: (2017) -
NK cells in hypoxic skin mediate a trade-off between wound healing and antibacterial defence
por: Michal Sobecki, et al.
Publicado: (2021) -
Activation of the Complement System in Patients with Cancer Cachexia
por: Min Deng, et al.
Publicado: (2021) -
Amelioration of muscle wasting by gintonin in cancer cachexia
por: Yoseph Toni Wijaya, et al.
Publicado: (2021) -
Silk peptide treatment potentiates natural killer cell activity in vitro and induces natural killer cell maturation and activation in mouse splenocytes
por: Sun-Hee Jang, et al.
Publicado: (2019)